In recent years, there has been a paradigm shift in our understanding of the brain-gut axis. The growth of evidence detailing the bidirectional interactions between the gut microbiome and the brain supports a comprehensive model that integrates the central nervous, gastrointestinal, and immune systems with this newly discovered organ. Clinical studies have shown potential for novel treatment targets including functional gastrointestinal disorders such as irritable bowel syndrome (IBS) and a wide range of psychiatric and neurologic disorders.
This session:
- describes the current Rome IV criteria to diagnose IBS;
- discusses the mechanisms of central and peripheral pain signalling which contribute to the pathophysiology of IBS and
- discusses the current evidence based non-pharmacological therapies for IBS.
This session was offered as part of the Clinical Nutrition Web Series in October 2020 along with these 3 other presentations also available on LOD:
- Diet and nutrition therapies, state of the art update in Inflammatory Bowel Disease
- Navigating ethical dilemmas for dietitians
- Let's problem solve some enterostomy tube care and management challenges!
Date of Presentation: October 28, 2020, Calgary CND
Speaker: Yasmin Nasser MD, PhD, FRCPC, Clinical Assistant Professor in the Department of Medicine and a clinician-scientist in the Division of Gastroenterology and Hepatology, University of Calgary
Materials:
- Video presentation (63 minutes)
- Presentation slides (pdf)
- Audio file (mp3 file)
Cost: $19.95 for members; $39.95 for non-members; $9.95 for students
